Delivery Order SPE2DB20D3101-SPE2DB20FG9Z7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order worth $1,311.38 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,089.55 delivery order was issued by the Defense Logistics Agency (DLA) for the "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" requirement. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,099.76 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of December 1, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for a Prime Vendor Pharmaceutical Branch-Philadelphia contract with the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $3,934.14, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 16, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is a firm fixed-price contract valued at $2,337.72, with a performance period through April 16, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,547.32 firm-fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia and has a completion date of November 27, 2020. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the provision of a Prime Vendor Pharmaceutical Branch-Philadelphia. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,105.36 and an ultimate completion date of July 8, 2021. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a prime vendor pharmaceutical branch in Philadelphia for the Defense Logistics Agency (DLA). The $11,636.45 delivery order contract has a firm fixed price and runs through November 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical Branch in Philadelphia. The $4,299.21 firm-fixed-price delivery order contract has a completion date of July 7, 2021. This is not a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $50,327.73 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) for the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB20FG9Z7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order with the Defense Logistics Agency (DLA). The $1,158.00 firm fixed-price contract has a completion date of September 2, 2020 and was awarded on September 1, 2020. It is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities, to support military and veterans' healthcare programs globally. Amerisourcebergen also maintains a separate $750,000.00 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/1/20 |